SCHEMBL6444746

SCHEMBL6444746

O=C1C(Cl)=C(c2ccc(Cl)c(Cl)c2)C(=O)N1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD51 Q06609 2/20 0.50
NR1H2 P55055 2/20 0.47
NR1H3 Q13133 2/20 0.47
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 3/20 0.46
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TP53 P04637 2/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
APAF1 O14727 1/20 0.45
CYP1A2 P05177 1/20 0.45
BCHE P06276 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426484 0.81 APAF1 (0.52) RAD51NR1H2NR1H3MAPTALDH1A1
SCHEMBL28080842 0.79 APAF1 (0.57) RAD51NR1H2NR1H3MAPTALDH1A1
SCHEMBL6427000 0.78 NR1H2 (0.60) RAD51NR1H2NR1H3MAPTALDH1A1
SCHEMBL6431729 0.78 NR1H2 (0.51) NR1H2NR1H3MAPTALDH1A1MAPK1
SCHEMBL5049894 0.77 ELANE (0.64) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL6427989 0.76 CASP1 (0.51) NR1H2NR1H3MAPTALDH1A1MAPK1
SCHEMBL6427927 0.75 MAPT (0.52) NR1H2NR1H3MAPTALDH1A1MAPK1
SCHEMBL6428843 0.74 NR1H2 (0.52) NR1H2NR1H3MAPTALDH1A1MAPK1
SCHEMBL6466541 0.74 L3MBTL1 (0.51) NR1H2NR1H3MAPTALDH1A1MAPK1
SCHEMBL6427708 0.74 NR1H2 (0.50) NR1H2NR1H3MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed